CRISPR Gene Editing to Be Tested on People by 2017, Says Editas

By | November 5, 2015

A biotechnology company says it will test advanced gene-engineering methods to treat blindness.
The biotechnology startup Editas Medicine intends to begin tests of a powerful new form of gene repair in humans within two years.

Leave a Reply